Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302587 · ClinicalTrials.gov registry record
A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
A clinical trial, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- 306
- Enrollment target
NCT01302587 is a clinical trial that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 306 participants.
The verdict
NCT01302587 has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
This study is evaluating the effectiveness of a dose counter for an inhaler device used to deliver medication to people diagnosed with asthma or COPD.
Interventions
- DRUG Albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302587
The ClinicalTrials.gov registry entry for NCT01302587 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Albuterol is the first listed.
NCT01302587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302587 about?
NCT01302587 is a clinical study titled "A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)". This study is evaluating the effectiveness of a dose counter for an inhaler device used to deliver medication to people diagnosed with asthma or COPD.
What is the current status of trial NCT01302587?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2011-03. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01302587?
The interventions under investigation include: Albuterol (DRUG).
Who is sponsoring clinical trial NCT01302587?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.